The latest studies from the European Association for the Study of Diabetes (EASD) annual meeting, rounded up by Mark Greener
Wegovy could reduce the risk of adverse cardiovascular events by 20%, marking an ‘important step forward’ in tackling the consequences of obesity
Tirzepatide, a type-2 diabetes drug has been recommended as a treatment for obesity to help patients 'live longer and healthier lives'
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support
